Atlas Trials

Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab

Clinical trial NCT01249937 · UNKNOWN

Trial details

NCT number
NCT01249937
Sponsor
University Health Network, Toronto
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Wet Macular Degeneration
Start date
2011-01-01
Primary completion
2011-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.